Letters


 

The National Association of Medicaid Directors sent a letter to the leaders of the House Energy and Commerce Committee regarding the impact to the Medicaid program from federal legislative efforts to incentivize and expedite high-cost cure-like pharmaceutical treatments and devices. 

The National Association of Medicaid Directors submitted a letter to the Centers for Medicare and Medicaid Services Acting Administrator Slavitt. The letter acknowledges progress made to improve Medicaid and Exchange interactions and calls for additional steps to improve the beneficiary experience and efficiency of operations. 

NAMD submitted comments to the Centers for Medicare and Medicaid Services in response to the Medicare Advantage Capitation Rates, Part C and Part D Payment Policies and 2016 Call Letter. NAMD urges CMS to expedite action to better support a viable delivery system for the Medicare-Medicaid dual eligible population. 

NAMD submitted comments to the Substance Abuse and Mental Health Services Administration (SAMHSA) on the draft criteria for the state-certified community behavioral health clinic demonstration enacted under Sec. 223 of the Protecting Access to Medicare Act of 2014. The letter focuses on the need to finalize a CCBHC framework that is flexible enough to support states and clinics in enhancing care for those with behavioral health conditions, regardless of their starting place.

NAMD submitted comments to the Centers for Medicare and Medicaid Services to inform the development of the prospective payment system (PPS) for the certified community behavioral health clinic (CCBHC) demonstration. This demonstration, which was enacted under the Protecting Access to Medicare Act, will be a 2-year pilot project under which eight states will develop a PPS for CCBHCs.

In this letter, NAMD addressed a variety of issues impacting dually eligible Medicare-Medicaid beneficaries, including the Financial Alignment Demonstrations and Dual Special Needs Plans, in order to enhance the care delivered to this vulnerable population.

Jan. 12, 2015 response letter from CMS.

NAMD submitted comments to the Substance Abuse and Mental Health Services Administration (SAMHSA) on the criteria for the state-certified community behavioral health clinic (CCBHC) demonstration enacted under Sec. 223 of the Protecting Access to Medicare Act of 2014. The comments focus on maximizing participation and success for those states interested in leveraging this opportunity to build capacity and advance practice transformation in their behavioral health systems.

NAMD contacted CMCS Director Cindy Mann and CMMI Director Dr. Patrick Conway to provide strategic direction for CMS’ Innovation Accelerator Program (IAP). The three overarching themes addressed are: CMS’s technical assistance must be aligned with overall federal agency policy; CMS must be engaged with and focused on Medicaid agencies; and the IAP must be flexible enough to adapt to state needs. 

Today the National Association of Medicaid Directors sent the attached letter to the leaders of the Senate Finance and HELP and House Energy & Commerce and Ways & Means committees regarding the current situation with break through prescription drug treatments. The letter addresses the challenges presented by new hepatitis C treatments.

In this letter, the fourth in a series of recommendations to the Center for Medicaid and CHIP Services (CMCS) to inform its ongoing work in modernizing Medicaid managed care regulations, NAMD provides recommendations on quality measure development and implementation.

Pages

© 2012 National Association of Medicaid Directors
444 North Capitol Street, Suite 524
Washington, D.C. 20001
202.403.8620